This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Medicaid Drug Rebate Program (MDRP) Summit 2024
September 23-25, 2024
Delivered as a Hybrid EventChicago Marriott Downtown Magnificent Mile, Chicago, IL

Katheryne Richardson, PharmD
Vice President, Global Pricing and Health Systems Analytics at Bristol Myers Squibb


Dr. Richardson is the Vice President, Global Pricing and Health Systems Analytics for Bristol-Myers Squibb. In this role, Dr. Richardson is responsible for leading US and WW pricing, which includes pricing execution and contract operations, government pricing, and pricing policy analytics functions.

Dr. Richardson formerly served as the VP Global Healthcare Strategy and Pricing Analytics and separately as Executive Director 340B Strategy for BMS. In those roles she collaborated across the organization to drive alignment cross-functionally, and she supported BMS teams in ongoing external interactions with our customers, payers, and trade groups on highly complex topics such as 340B and the Inflation Reduction Act (IRA).

Prior to joining Bristol-Myers Squibb, Katheryne was the Vice President of Apexus, the 340B Prime Vendor Program, where she was responsible for the executive oversight of teams responsible for policy, education, and compliance. As a recognized thought-leader, she led teams that created industry 340B standard-setting programs, and she served on the senior leadership team responsible for the strategic direction, financial oversight, and overall business operations of the company.

Katheryne has also held a variety of roles of increasing responsibility in clinical practice, consulting, and public health, including experience at and with the Health Resources and Services Administration, the Food and Drug Administration, the National Institutes of Health, and the Centers for Disease Control and Prevention.

Dr. Richardson is a graduate of the University of Kentucky College of Pharmacy, where she received her B.S. and PharmD degrees. She received a certificate in Health Economics and Outcomes Research from the American Society of Health System Pharmacists and is a licensed pharmacist in Virginia and Florida.

Agenda Sessions

  • Executive Strategy Summit